Fecha de publicación: -- Fuente: Labiotech Lugar: In Depth The concept of targeted therapeutics is often traced back to German Nobel laureate Paul Ehrlich’s “magic bullet” in 1907, which envisioned a single entity that could both recognize a disease target and deliver a therapeutic effect specifically to it. This vision laid the conceptual foundation for modern conjugate drugs that followed.  The first major success in […]
The post How AOCs are advancing targeted therapeutics appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.